The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor cells (CTC) as potential biomarkers in neoadjuvant chemotherapy of muscle invasive bladder cancer (MIBC).
 
Ajjai Shivaram Alva
Consulting or Advisory Role - Eisai
Research Funding - BIND Therapeutics (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Novartis (Inst); Prometheus (Inst)
 
Stephanie Daignault-Newton
No Relationships to Disclose
 
Tamara Huebner
No Relationships to Disclose
 
Melanie Clark
No Relationships to Disclose
 
Maha Hussain
Consulting or Advisory Role - Genmab; Johnson & Johnson; Paradigm; Synthon
Research Funding - Astellas Pharma (Inst); Genentech (Inst); ImClone Systems (Inst); Lilly (Inst); Medivation (Inst); Millennium (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - TITLE: Dual Inhibition of MET and VEGF for the treatment of castration resistant prostate cancer and osteoblastic bone metastases. Applicant/Proprietor Exelexis, Inc. Application No/Patent No. 11764665.4- 1464 Application No/Pa; TITLE: METHOD OF TREATING CANCER Docket No: Serial Number: 224990/10-016P2/311733 61/481/671 Application Filed on: 5/2/2011; TITLE: SYSTEMS AND METHODS FOR TISSUE IMAGING, 3676 Our File: Serial Number: UM-14437/US-1/PRO 60/923,385 UM-14437/US-2/ORD 12/101,7
 
Cristian Ionescu
Employment - Fluxion Biosciences
Stock and Other Ownership Interests - Fluxion Biosciences
 
Mike Schwartz
Employment - Fluxion Biosciences
Leadership - Fluxion Biosciences
Stock and Other Ownership Interests - Fluxion Biosciences